Patent: 8,119,129
✉ Email this page to a colleague
Summary for Patent: 8,119,129
Title: | Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases |
Abstract: | Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders. |
Inventor(s): | Jure-Kunkel; Maria (Plainsboro, NJ), Lee; Francis Y. (Yardley, PA) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 12/462,168 |
Patent Claims: | see list of patent claims |
Details for Patent 8,119,129
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bristol-myers Squibb Company | YERVOY | ipilimumab | Injection | 125377 | 03/25/2011 | ⤷ Try a Trial | 2028-08-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |